We found that increased serum NfL and GFAP levels at baseline were associated with an accelerated rate of both global and regional brain atrophy; however, only longitudinal changes in serum NfL tracked the changes in both global and regional brain volumes over 5 years. The gene discussed is GFAP; the disease is Brain atrophy.